Both the lack of NLRP6 and its downregulation are related to increased liver injury and the progression of different liver diseases such as liver fibrosis, non-alcoholic steatohepatitis (NASH), and alcoholic hepatitis (AH)80–85. The gene discussed is NLRP6; the disease is metabolic dysfunction-associated steatohepatitis.